Hydrostatic pressure as an office procedure for congenital nasolacrimal duct obstruction

Chaim Stolovitch1, Adi Michaeli

  • 1Department of Ophthalmology, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. stolovic@netvision.net.il

Insights

Hydrostatic pressure effectively treats congenital nasolacrimal duct obstruction (CNDO) in infants. Success rates are highest in younger infants, but the procedure can be safely repeated at any age.

Area of Science:

  • Ophthalmology
  • Pediatric Medicine
  • Surgical Innovation

Background:

  • Congenital nasolacrimal duct obstruction (CNDO) affects 5% to 20% of infants.
  • CNDO can cause persistent epiphora and discharge.
  • Effective treatment options are crucial for infant well-being.

Purpose of the Study:

  • To evaluate the success rate of hydrostatic pressure (Crigler method) for treating CNDO.
  • To determine the efficacy of hydrostatic pressure as an outpatient procedure.
  • To assess the impact of patient age on treatment success.

Main Methods:

  • A total of 742 infants with CNDO were treated with hydrostatic pressure.
  • The noninvasive procedure could be repeated up to three times.
  • Success was defined as the absence of epiphora or discharge.

Main Results:

  • The overall success rate for the study group was 45% in children up to one year of age.
  • First-attempt success was 46%, with subsequent attempts yielding 35% and 38% success.
  • Success rates were significantly higher in infants younger than two months (56%) compared to older infants.

Conclusions:

  • Hydrostatic pressure is an effective treatment for infant CNDO, reducing associated morbidity.
  • Early intervention (infants up to two months) yields the highest success rates.
  • The procedure is safe, repeatable, and recommended for all infants with CNDO.
Abstract

Related Concept Videos

Suctioning the Nasopharyngeal Airway01:29

Suctioning the Nasopharyngeal Airway

Nasopharyngeal suctioning is a procedure to remove secretions from the upper part of the respiratory tract that the patient cannot clear independently. It helps maintain airway patency and prevents complications such as aspiration pneumonia.
Equipment Required
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...